Suppr超能文献

硫唑嘌呤治疗失败后用6-巯基嘌呤成功治疗自身免疫性肝炎。

The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine.

作者信息

Pratt D S, Flavin D P, Kaplan M M

机构信息

Division of Gastroenterology, New England Medical Center, Boston, Massachusetts, USA.

出版信息

Gastroenterology. 1996 Jan;110(1):271-4. doi: 10.1053/gast.1996.v110.pm8536867.

Abstract

Although the treatment of choice for autoimmune hepatitis is glucocorticoids, their side effects make long-term use undesirable. Therefore, other immunosuppressive agents have been used to replace glucocorticoids in the long-term treatment of autoimmune hepatitis, including azathioprine, a purine analogue. It is derived from 6-mercaptopurine, and these two drugs are often used interchangeably. However, these drugs have different toxicity profiles and may have clinically relevant differences in immunosuppressive activity in individual patients. We report 3 patients with autoimmune hepatitis who either could not tolerate or failed to improve on azathioprine but responded well to 6-mercaptopurine.

摘要

尽管自身免疫性肝炎的首选治疗药物是糖皮质激素,但其副作用使得长期使用并不理想。因此,其他免疫抑制剂已被用于在自身免疫性肝炎的长期治疗中替代糖皮质激素,包括嘌呤类似物硫唑嘌呤。它由6-巯基嘌呤衍生而来,这两种药物常可互换使用。然而,这些药物具有不同的毒性特征,并且在个体患者的免疫抑制活性方面可能存在临床相关差异。我们报告了3例自身免疫性肝炎患者,他们要么无法耐受硫唑嘌呤,要么使用硫唑嘌呤后病情未改善,但对6-巯基嘌呤反应良好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验